Blue Jet Healthcare Limited (BLUEJET.BO)
BSE · INR · Healthcare · Biotechnology
₹497.65 (+2.64%) as of
Key statistics
- Market cap
- 86.33B
- P/E (TTM)
- 37.47
- Forward P/E
- 25.53
- EPS (TTM)
- 13.28
- Dividend yield
- 0.25%
- 52-week range
- 325.20 – 688.00
- Beta
- 0.64
- Revenue (TTM)
- 8.86B
- Profit margin
- 26.52%
- Analyst target
- ₹568.00
- Volume
- 6.01k
About Blue Jet Healthcare Limited
Blue Jet Healthcare Limited engages in the manufacturing and sale of artificial sweeteners, pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in products. It provides contrast media intermediates, as well as end-to-end solutions from process development and commercialization of NCEs, advance intermediates, API, and building blocks. The company develops, manufactures, and markets saccharin and related supplies to healthcare, pharma, animal feed, and food and beverages industries. It has operations in India, Norway, France, the United States, Denmark, Thailand, Spain, Italy, Sweden, and internationally. Blue Jet Healthcare Limited was incorporated in 1968 and is headquartered in Thane, India.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Thane, India
- Employees
- 581
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.
Related stocks
- Ashika Credit Capital Ltd. (ASHIKA.BO)
- SANGHI INDUSTRIES LTD (SANGHIIND.NS)
- Chemkart India Limited (CHEMKART.BO)
- PNGS GARGI FASHION JEWELLERY L (GARGI.BO)
- PATIL AUTOMATION LIMITED (PATILAUTOM-SM.NS)
- MERCURY EV-TECH LIMITED (MERCURYEV.BO)
- GARWARE HI-TECH FILMS LIMITED (GRWRHITECH.BO)
- TVS SRICHAKRA LIMITED (TVSSRICHAK.NS)